Repligen Acquires BioLife Solutions for $1.5 Billion
July 23, 2026
Repligen has entered into a definitive agreement to acquire BioLife Solutions in a cash-and-stock transaction with an enterprise value of approximately $1.5 billion. The deal is expected to close in the fourth quarter of 2026, subject to BioLife shareholder approval and regulatory clearances.
- Buyers
- Repligen Corporation
- Targets
- BioLife Solutions
- Industry
- Healthcare Services
- Location
- Washington, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.